Incidence of herpes simplex virus type 2 positivity among women living with human immunodeficiency virus in South Africa
International Journal of STD & AIDS · 2024
DOI: 10.1177/09564624231201189 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of STD & AIDS, 2024. Verfasst von Kwabena Asare und 8 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa. Hauptthemen laut MEDLINE: HIV Infections, Vaginosis, Bacterial, Herpes Genitalis, Herpes Simplex. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
For women living with HIV (WLHIV), co-infection with herpes simplex virus type 2 (HSV-2) causes severe genital ulcers and presents additional challenges for their HIV care. To inform preventive strategies, we aimed to determine the incidence and risk factors of HSV-2 positivity in a prospective cohort of South African women.
Methods
The CAPRISA 002 study enrolled women at acute HIV infection between 2004 and 2020. HSV-2 testing was conducted by multiplex polymerase chain reaction (PCR) assay on collected vaginal swabs up to twice annually during follow-up. We calculated incidence as the number of new cases per 100 person-years (PYs) and used Cox-proportional-hazard regression to identify factors associated with time-to-HSV-2 PCR positivity.
Results
At enrolment, the median age of 171 women was 24 years, interquartile range (IQR 21–28), and the estimated median days since HIV infection was 42 (IQR 22–65). Of participants tested at enrolment, HSV-2 antibody prevalence was 81.4% (105/129), and 10.6% (12/113) were positive by PCR. Among 147 women with a prior negative HSV-2 PCR diagnosis, we observed 47 new HSV-2 PCR positive cases over 424.4 PYs of follow-up, yielding an incidence rate of 11.1 cases per-100-PYs. HSV-2 PCR positivity incidence was higher among younger women (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
- Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
- Health Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban, South Africa.
- Department of Medical Microbiology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
- Department of Epidemiology, Columbia University, New York, NY, USA.
- Centre for Rural Health, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
ORCID-Profile: Kwabena Asare
Förderung
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Asare, K., Ngcapu, S., Osman, F., Mindel, A., Naicker, N., Khanyile, M., Karim, S. S. A., Tomita, A., & Garrett, N. (2024). Incidence of herpes simplex virus type 2 positivity among women living with human immunodeficiency virus in South Africa. International Journal of STD & AIDS. https://doi.org/10.1177/09564624231201189
Vancouver
Asare K, Ngcapu S, Osman F, Mindel A, Naicker N, Khanyile M, et al. Incidence of herpes simplex virus type 2 positivity among women living with human immunodeficiency virus in South Africa. International Journal of STD & AIDS. 2024. doi:10.1177/09564624231201189
BibTeX
@article{Asare2024,
author = {Asare, Kwabena and Ngcapu, Sinaye and Osman, Farzana and Mindel, Adrian and Naicker, Nivashnee and Khanyile, Mlungisi and Karim, Salim S Abdool and Tomita, Andrew and Garrett, Nigel},
title = {Incidence of herpes simplex virus type 2 positivity among women living with human immunodeficiency virus in South Africa},
journal = {International Journal of STD & AIDS},
year = {2024},
doi = {10.1177/09564624231201189}
}
EUVIMED